Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2025-12-24 @ 4:40 PM
NCT ID: NCT02277366
Eligibility Criteria: Inclusion Criteria: * Patient is over 40 years in age and is a heavy cigarette smoker.(smoking index is over 400) * Patient has been coughing irritably for 2-3 weeks with a failed treatment and without obvious causes. * The nature of cough changes in a patient who has chronic respiratory disease. * Patient has blood-stained sputum persistently or repeatedly without obvious causes. Patient will be included if accorded with any item of above. Exclusion Criteria: * Patient has dysrhythmia or cardiovascular disease that poses a risk during exercise. * Patient has uncontrollable hypertension (SBP \> 180mmHg). * Patient has severe organ dysfunction (shock, severe hepatic and renal dysfunction, massive hemorrhage of upper gastrointestine, diffuse intravascular coagulation(DIC) and massive hemoptysis,etc). * Patient has blood coagulation disorders (PT\>2 times the upper limit of normal(ULN) or Platelet(PLT)\<50000/ul). * Patient has severe dyspnea. * Patient is allergic to local anesthetic. * Patient is unable to provide informed consent. * Patient is not an appropriate candidate for or is unable to tolerate flexible bronchoscopy procedures. * Patient has any disease or condition that interferes with completion of initial or follow-up assessments of the effectiveness endpoints. * Patient has demonstrated unwillingness or inability to complete screening or baseline data collection procedures. * Patient participated in a study of an investigational drug or device within the past 30 days prior to participation in this study, or is currently participating in another clinical study. * Patient has pulmonary lesions suspected to be cancer from CT images. * Female patient of childbearing potential has a positive result from a pregnancy test.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT02277366
Study Brief:
Protocol Section: NCT02277366